C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
167/130, 195/1.2
C12N 7/01 (2006.01) A61K 39/12 (2006.01) A61K 39/285 (2006.01) C07K 14/07 (2006.01) C07K 14/445 (2006.01) C12N 15/863 (2006.01) A61K 39/00 (2006.01)
Patent
CA 1341245
The present invention relates to recombinant vaccinia viruses which are derived from the modified virus Ankara (MVA) and which contain a DNA sequence which codes for a foreign antigen. The invention also relates to vaccines which contain a virus of this type in a form suitable for injection, as well as to a method for the preparation thereof. Furthermore the invention relates to the use of a recombinant vaccinia virus MVA for the preparation of heterologous proteins in eukariotic cells.
586433
Alpharma (luxembourg) S.a.r.l.
F. Hoffmann-La Roche & Co. Aktiengesellschaft
Gowling Lafleur Henderson Llp
LandOfFree
Recombinant vaccinia virus mva does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant vaccinia virus mva, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant vaccinia virus mva will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1187046